September 26, 2019
Drugmaker Avanir Pharmaceuticals has agreed to shell out more than $108 million in criminal penalties, forfeiture and civil damages for an alleged kickback scheme that involved the company paying physicians to prescribe its drug Nuedexta, the U.S. Department of Justice announced Thursday.